Press releases

DEINOVE and TWB undertake a collaborative project to optimize the metabolic fluxes of Deinococcus . This partnership aims to strengthen...

The Tech 40 label recognizes particularly outstanding listed technology companies. Deinove is one of the 40 companies selected from among...

Cash position sharply improved by the December 2015 capital increase Reduction of net loss to €6.4m, vs. €6.5m in 2014 Growth in operating...

The two companies have started a collaboration to demonstrate the synergy of their respective technologies for the valorization of non-food...

The ROTH conference brings together several thousand U.S. investors focused on small and mid-cap growth companies. Emmanuel PETIOT will...

DEINOVE received from the US an agreement for issuance of its patent PF7: "Bacteria and uses thereof", which refers to the metabolic...

Increased number of target molecules with now five carotenoids produced at the lab scale paving the way for different markets Increased...

DEINOVE (Alternext Paris: ALDEI), a biotech company developing innovative processes for producing biofuels and bio-based chemicals from non...

Montpellier, 23 December 2015 – DEINOVE (Alternext Paris: ALDEI), a biotech company developing innovative processes for producing biofuels...

Total demand of approximately €11.8 million, i.e. an oversubscription rate of 128% of the offer Full exercise of the extension clause...